Sichuan Kelun Pharmaceutical Co Ltd Asset Resilience Ratio
Sichuan Kelun Pharmaceutical Co Ltd asset resilience ratio. Sichuan Kelun Pharmaceutical Co Ltd (002422) has an Asset Resilience Ratio of 8.05% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Sichuan Kelun Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sichuan Kelun Pharmaceutical Co Ltd (2011–2025)
Asset resilience ratio of Sichuan Kelun Pharmaceutical Co Ltd from 2011 to 2025. This chart shows how Sichuan Kelun Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See free cash flow generation of Sichuan Kelun Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Sichuan Kelun Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 002422 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥3.34 Billion | 8.05% |
| Total Liquid Assets | CN¥3.34 Billion | 8.05% |
Asset Resilience Insights
- Limited Liquidity: Sichuan Kelun Pharmaceutical Co Ltd maintains only 8.05% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sichuan Kelun Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Sichuan Kelun Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AstraZeneca PLC
MX:AZNN |
Drug Manufacturers - General | 0.03% |
|
AstraZeneca PLC
LSE:AZN |
Drug Manufacturers - General | 0.06% |
|
AbbVie Inc
NYSE:ABBV |
Drug Manufacturers - General | 0.02% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 5.33% |
|
Novo Nordisk A/S
CO:NOVO-B |
Drug Manufacturers - General | 0.09% |
|
Merck & Company Inc
NYSE:MRK |
Drug Manufacturers - General | 0.22% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Novartis AG
MX:NVSN |
Drug Manufacturers - General | 0.08% |
Sichuan Kelun Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2011–2025)
Sichuan Kelun Pharmaceutical Co Ltd asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Sichuan Kelun Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 3.66% | CN¥1.46 Billion ≈ $213.17 Million |
CN¥39.83 Billion ≈ $5.83 Billion |
-1.49pp |
| 2024-12-31 | 5.15% | CN¥1.92 Billion ≈ $281.13 Million |
CN¥37.32 Billion ≈ $5.46 Billion |
+0.51pp |
| 2023-12-31 | 4.64% | CN¥1.69 Billion ≈ $247.46 Million |
CN¥36.45 Billion ≈ $5.33 Billion |
+3.33pp |
| 2022-12-31 | 1.31% | CN¥448.11 Million ≈ $65.57 Million |
CN¥34.21 Billion ≈ $5.01 Billion |
+0.17pp |
| 2021-12-31 | 1.14% | CN¥359.53 Million ≈ $52.61 Million |
CN¥31.54 Billion ≈ $4.62 Billion |
+0.31pp |
| 2020-12-31 | 0.83% | CN¥265.42 Million ≈ $38.84 Million |
CN¥32.01 Billion ≈ $4.68 Billion |
+0.88pp |
| 2019-12-31 | -0.05% | CN¥-17.22 Million ≈ $-2.52 Million |
CN¥31.49 Billion ≈ $4.61 Billion |
-0.74pp |
| 2018-12-31 | 0.68% | CN¥200.00 Million ≈ $29.27 Million |
CN¥29.34 Billion ≈ $4.29 Billion |
-1.13pp |
| 2017-12-31 | 1.81% | CN¥507.00 Million ≈ $74.19 Million |
CN¥27.99 Billion ≈ $4.10 Billion |
+1.30pp |
| 2016-12-31 | 0.51% | CN¥120.00 Million ≈ $17.56 Million |
CN¥23.41 Billion ≈ $3.43 Billion |
-0.77pp |
| 2015-12-31 | 1.28% | CN¥290.00 Million ≈ $42.44 Million |
CN¥22.58 Billion ≈ $3.30 Billion |
+1.35pp |
| 2014-12-31 | -0.07% | CN¥-14.93 Million ≈ $-2.19 Million |
CN¥21.20 Billion ≈ $3.10 Billion |
+0.06pp |
| 2013-12-31 | -0.13% | CN¥-23.88 Million ≈ $-3.49 Million |
CN¥17.95 Billion ≈ $2.63 Billion |
+0.02pp |
| 2012-12-31 | -0.15% | CN¥-22.59 Million ≈ $-3.31 Million |
CN¥14.93 Billion ≈ $2.18 Billion |
+0.02pp |
| 2011-12-31 | -0.17% | CN¥-18.02 Million ≈ $-2.64 Million |
CN¥10.47 Billion ≈ $1.53 Billion |
-- |
About Sichuan Kelun Pharmaceutical Co Ltd
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, ve… Read more